Search research articles
Contact Us
Filters
Showing results (151-160 of 326) with videos related to
Page
of 33
Sort By:
Gut
|
September 18, 2025
Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study
Jing Tong Tan, Xianhua Mao, David Tak-Wai Lui, et al.
Hepatology International
|
January 24, 2019
Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection
Lung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Journal of Travel Medicine
|
May 5, 2021
Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes
Ye Peng, Dengwei Zhang, Ting Chen, et al.
Idcases
|
June 27, 2018
Fatal pancytopenia due to albendazole treatment for strongyloidiasis
Fanfan Xing, Haiyan Ye, Jin Yang, et al.
Gut
|
August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
Xianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Ebiomedicine
|
April 7, 2024
Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome
Saisai Zhang, Hau-Tak Chau, Hein Min Tun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 14, 2025
Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus
Ho Yu Ng, Lina Zhang, Jing Tong Tan, et al.
Journal of Hepatology
|
June 7, 2020
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Digestive Diseases and Sciences
|
March 8, 2022
Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection
Lung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 20, 2016
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong, Wai-Kay Seto, Ka-Shing Cheung, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 326) with videos related to
Sort By:
Page
of 33
Gut
|
September 18, 2025
Glycaemic control is a modifiable risk factor for pancreatic cancer development in patients with diabetes: a population-based cohort study
Jing Tong Tan, Xianhua Mao, David Tak-Wai Lui, et al.
Hepatology International
|
January 24, 2019
Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection
Lung-Yi Mak, Danny Ka-Ho Wong, Wai-Kay Seto, et al.
Journal of Travel Medicine
|
May 5, 2021
Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes
Ye Peng, Dengwei Zhang, Ting Chen, et al.
Idcases
|
June 27, 2018
Fatal pancytopenia due to albendazole treatment for strongyloidiasis
Fanfan Xing, Haiyan Ye, Jin Yang, et al.
Gut
|
August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
Xianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Ebiomedicine
|
April 7, 2024
Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome
Saisai Zhang, Hau-Tak Chau, Hein Min Tun, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 14, 2025
Gut Microbiota Predicts Treatment Response to Empagliflozin Among MASLD Patients Without Diabetes Mellitus
Ho Yu Ng, Lina Zhang, Jing Tong Tan, et al.
Journal of Hepatology
|
June 7, 2020
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Digestive Diseases and Sciences
|
March 8, 2022
Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection
Lung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 20, 2016
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong, Wai-Kay Seto, Ka-Shing Cheung, et al.
Page
of 33